Literature DB >> 9819834

Does the covariance structure matter in longitudinal modelling for the prediction of future CD4 counts?

J M Taylor1, N Law.   

Abstract

We investigate the importance of the assumed covariance structure for longitudinal modelling of CD4 counts. We examine how individual predictions of future CD4 counts are affected by the covariance structure. We consider four covariance structures: one based on an integrated Ornstein-Uhlenbeck stochastic process; one based on Brownian motion, and two derived from standard linear and quadratic random-effects models. Using data from the Multicenter AIDS Cohort Study and from a simulation study, we show that there is a noticeable deterioration in the coverage rate of confidence intervals if we assume the wrong covariance. There is also a loss in efficiency. The quadratic random-effects model is found to be the best in terms of correctly calibrated prediction intervals, but is substantially less efficient than the others. Incorrectly specifying the covariance structure as linear random effects gives too narrow prediction intervals with poor coverage rates. Fitting using the model based on the integrated Ornstein-Uhlenbeck stochastic process is the preferred one of the four considered because of its efficiency and robustness properties. We also use the difference between the future predicted and observed CD4 counts to assess an appropriate transformation of CD4 counts; a fourth root, cube root and square root all appear reasonable choices.

Entities:  

Mesh:

Year:  1998        PMID: 9819834     DOI: 10.1002/(sici)1097-0258(19981030)17:20<2381::aid-sim926>3.0.co;2-s

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  18 in total

1.  Semiparametric Stochastic Modeling of the Rate Function in Longitudinal Studies.

Authors:  Bin Zhu; Jeremy M G Taylor; Peter X-K Song
Journal:  J Am Stat Assoc       Date:  2011-12-01       Impact factor: 5.033

2.  Continuous Time Nonstationary Correlation Models for Sparse Longitudinal Data.

Authors:  Vinay K Cheruvu; Jeffrey M Albert
Journal:  Model Assist Stat Appl       Date:  2019-07-18

3.  Stochastic functional data analysis: a diffusion model-based approach.

Authors:  Bin Zhu; Peter X-K Song; Jeremy M G Taylor
Journal:  Biometrics       Date:  2011-03-18       Impact factor: 2.571

4.  Ornstein-Uhlenbeck threshold regression for time-to-event data with and without a cure fraction.

Authors:  Roger Erich; Michael L Pennell
Journal:  Lifetime Data Anal       Date:  2014-08-06       Impact factor: 1.588

5.  Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.

Authors:  Marcel Wolbers; Abdel Babiker; Caroline Sabin; Jim Young; Maria Dorrucci; Geneviève Chêne; Cristina Mussini; Kholoud Porter; Heiner C Bucher
Journal:  PLoS Med       Date:  2010-02-23       Impact factor: 11.069

6.  Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men.

Authors:  Chun Chao; Lisa P Jacobson; Donald Tashkin; Otoniel Martínez-Maza; Michael D Roth; Joseph B Margolick; Joan S Chmiel; Charles Rinaldo; Zuo-Feng Zhang; Roger Detels
Journal:  Drug Alcohol Depend       Date:  2008-01-03       Impact factor: 4.492

7.  Making predictions from complex longitudinal data, with application to planning monitoring intervals in a national screening programme.

Authors:  M J Sweeting; S G Thompson
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2012-04       Impact factor: 2.483

8.  Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.

Authors:  Nikos Pantazis; Charles Morrison; Pauli N Amornkul; Charlotte Lewden; Robert A Salata; Albert Minga; Tsungai Chipato; Harold Jaffe; Shabir Lakhi; Etienne Karita; Kholoud Porter; Laurence Meyer; Giota Touloumi
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

9.  New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon.

Authors:  Jacques D A Ndawinz; Xavier Anglaret; Eric Delaporte; Sinata Koulla-Shiro; Delphine Gabillard; Albert Minga; Dominique Costagliola; Virginie Supervie
Journal:  Bull World Health Organ       Date:  2015-06-01       Impact factor: 9.408

10.  The HIV RNA setpoint theory revisited.

Authors:  Ronald B Geskus; Maria Prins; Jean-Baptiste Hubert; Frank Miedema; Ben Berkhout; Christine Rouzioux; Jean-Francois Delfraissy; Laurence Meyer
Journal:  Retrovirology       Date:  2007-09-21       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.